Results 141 to 150 of about 115,762 (301)

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. [PDF]

open access: yesFront Immunol, 2022
Saleki K   +7 more
europepmc   +1 more source

Diagnosis and Management of Isolated Laryngeal Sarcoidosis: A Systematic Review

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective This study reviews the existing literature on patients diagnosed with sarcoidosis isolated to the larynx to improve our understanding of the diagnosis and management of this rare condition. Data Sources Embase, PubMed, Web of Science.
Raj Malhotra   +5 more
wiley   +1 more source

Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors. [PDF]

open access: yesCancer Immunol Res, 2022
Bajgain P   +7 more
europepmc   +1 more source

Nanomedicine Targeting Macrophage Immunometabolism in Atherosclerosis: Mechanisms and Therapeutic Prospects

open access: yesOrgan Medicine, EarlyView.
ABSTRACT Atherosclerosis, a chronic inflammatory–metabolic disorder, remains a leading cause of cardiovascular morbidity worldwide. This review explores the emerging paradigm of nanomedicine‐based targeting of macrophage immunometabolic reprogramming as a potentially transformative strategy for atherosclerosis treatment.
Zhenyu Liu, Wenfan Yang, Na Wang, Ya Wu
wiley   +1 more source

Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study. [PDF]

open access: yesIndian J Med Res, 2022
Asgari R   +5 more
europepmc   +1 more source

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review examines the epidemiological shift from hepatitis B virus (HBV) to metabolic dysfunction‐associated steatotic liver disease (MASLD) as the leading cause of cirrhosis globally. It highlights the distinct pathogenic mechanisms between HBV and MASLD cirrhosis and discusses evolving diagnostic tools and therapeutic strategies tailored to the ...
Hanqi Yu   +5 more
wiley   +1 more source

Unleasing Fas ligand

open access: yes
The use of Fas ligand could revolutionize the way that we target malignancies. Cancer has long been a fierce enemy; in the US, two million people received a cancer diagnosis in 2022, and 609,000 people lost their lives to the disease. Therefore, one of the main objectives in the field of biotechnology is the development of novel techniques to target ...
openaire   +1 more source

Diverse immunological roles of liver‐resident immune cells in liver diseases

open access: yesPrecision Medical Sciences, EarlyView.
Based on their origin and functional characteristics, LRICs can be classified into four categories. These cells differ in the focus of their immune functions in liver diseases, yet all exhibit the characteristic of functional bidirectionality.
Zhengyi Fan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy